The primary screening campaign occupies a key position in the preclinical drug discovery process. High-throughput screening (HTS) is used to identify molecules with suitable target-specific properties to develop a promising drug. In our fully automated laboratory, we can offer perfectly miniaturized, cost-effective assays for HTS campaigns. Our equipment enables both microplate-intensive screening of complex compound libraries on a large scale and focused screening of smaller sub-libraries consisting of well-selected, promising structural families. In addition to classical biochemical and cellular technologies for target-specific or phenotypic screening, our services also include fragment-based screening and NMR-based screening. The scientific question determines which screening technology is best suited to your project. We are prepared and well equipped to select the physiologically best screening technology for you.